Umedeor
Carlos Miragall is an accomplished finance professional with extensive experience in senior management roles across various industries. Currently serving as Advisor to the CEO and CFO at uMed since April 2022, Miragall has also held advisory positions for multiple companies since January 2020. Previous positions include CFO at QuoIntelligence and CDeX, and Chief Financial Officer at Panaseer, where significant funding was raised and company growth achieved. As a co-founder of Nextail Labs, a tech startup focused on innovative solutions for fashion retailers, Miragall contributed to optimizing retail distribution. Earlier career highlights include a Senior Manager role at A.T. Kearney and consulting positions at Bridgepoint and ZS Associates. Miragall holds multiple advanced degrees, including an MBA with Distinction from London Business School and is recognized for a strong academic background in economics and engineering.
This person is not in any teams
This person is not in any offices
Umedeor
uMed is a technology platform embedded across a global network of healthcare providers that automates the process of building prospective, protocolized patient registries. This enables sites to participate in dozens of programmes simultaneously without increasing overhead or burden on staff. For life science companies, uMed provides access toregulator quality data, where patients within those datasets can be compliantly re-engaged to support the aims of R&D and post-market teams